Exon 14 Deleted MET Receptor as a New Biomarker and Target in CancersAlexis B. Cortot, David Tulasne|JNCI Journal of the National Cancer Institute|2016Cited by 121
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1Benjamin Besse, Manuel Cobo, Céline Mascaux et al.|Annals of Oncology|2023Cited by 69